Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals | Baseline | Actual Performance | Long-Term Goal | |
|---|---|---|---|---|
| 2002 | 2006 | 2007 | 2010 | |
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44-years of age) | 197,000 | 106,000 | 146,000 | 168,000 |
| a. Prevalence of Chlamydia in high-risk women ≤ 25 years | 10.1%* | 13.1%* | 13.2%* | 15.1% |
| b. Prevalence of Chlamydia in women ≤ 25 years in family planning clinics | 5.6%* | 6.7%* | 6.9%* | 7.4% |
| c. Incidence of Gonorrhea/100,000 population in women 15–44 years of age | 279 | 290 | 290 | 296 |
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) | 2.4 | 3.3 | 3.8 | 2.2 |
| a. Incidence of P&S Syphilis/100,000 population - men | 3.8 | 5.6 | 6.6 | 7.2 |
| b. Incidence of P&S Syphilis/100,000 population - women | 1.1 | 1.0 | 1.1 | 1.2 |
| c. Incidence of Congenital Syphilis/100,000 live births | 10.2 | 9.3 | 10.5 | 9.4 |
| d. Black:white rate ratio of P&S Syphilis | 8:1 | 5.9:1 | 7:1 | 6.7:1 |
| GPRA Goals | Data Source |
|---|---|
| 1 | National Disease and Therapeutic Index (IMS Health). |
| 1–a | National Job Training Program. |
| 1–b | Regional Infertility Prevention Projects (IPP). |
| 1–c | STD Surveillance System (STDSS), CDC, NCHHSTP. |
| 2 | STD Surveillance System (STDSS), CDC, NCHHSTP. |
| 2–a | STD Surveillance System (STDSS), CDC, NCHHSTP. |
| 2–b | STD Surveillance System (STDSS), CDC, NCHHSTP. |
| 2–c | STD Surveillance System (STDSS), CDC, NCHHSTP. |
| 2–d | STD Surveillance System (STDSS), CDC, NCHHSTP. |
*Median state-specific chlamydia prevalence among women was not adjusted for changes in laboratory test method and associated increases in test sensitivity.
